SC Filed 2020-01-03 Event — SEC 0000899140-20-000007 →

Sarissa Capital Management LP → Regulus Therapeutics Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

18 filings by this filer

17 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Regulus Therapeutics Inc.

Filed	Form	Filer	Stake	Shares
2021-12-09	SC	Growth Equity Opportunities V, LLC	—	—	view →
2019-05-15	SC	Growth Equity Opportunities V, LLC	—	—	view →

Other Filings by Sarissa Capital Management LP

Filed	Form	Issuer	Stake	Shares
2025-03-17	SCHEDULE	Innoviva, Inc. INVA	4.70%	2,966,022	view →
2025-03-07	SCHEDULE	Innoviva, Inc. INVA	8.40%	5,237,161	view →
2022-07-06	SC	Alkermes plc. ALKS	—	—	view →
2022-01-10	SC	Alkermes plc. ALKS	—	—	view →
2021-11-19	SC	Alkermes plc. ALKS	—	—	view →
2021-09-10	SC	Alkermes plc. ALKS	—	—	view →
2021-05-27	SC	Alkermes plc. ALKS	—	—	view →
2021-05-25	SC	Innoviva, Inc. INVA	—	—	view →
2021-03-01	SC	IRONWOOD PHARMACEUTICALS INC IRWD	—	—	view →
2021-02-12	SC	Iterum Therapeutics plc ITRMF	—	—	view →
2020-12-14	SC	Innoviva, Inc. INVA	—	—	view →
2020-11-09	SC	IRONWOOD PHARMACEUTICALS INC IRWD	—	—	view →
2020-02-26	SC	IRONWOOD PHARMACEUTICALS INC IRWD	—	—	view →
2018-04-03	SC	EMMAUS LIFE SCIENCES, INC.	—	—	view →
2018-03-23	SC	APRICUS BIOSCIENCES, INC.	—	—	view →
2018-03-19	SC	NOVELION THERAPEUTICS INC.	—	—	view →
2018-01-31	SC	APRICUS BIOSCIENCES, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →